Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
By L. Hicks, L. Harrison, B. Flannery, J. Hadler, W. Schaffner, A. Craig, Delois M. Jackson, A. Thomas, B. Beall, R. Lynfield and 3 more. Journal of Infectious Diseases, 2007
778 citations recorded by the source corpus.
Subfields: Epidemiology, Immunology
View Paper: https://www.semanticscholar.org/paper/56a0facfb59e4b1b16747ed1f9a3af062ee80c96
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Brouwer
- D. van de Beek
- A. Tunkel
- T. Pilishvili
- M. Moore
- C. Whitney
- W. Schaffner
- C. Lexau
Citations in the corpus
- Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. (2010, background): “However, increases in the incidence of non-PCV7 serotypes in the general US population have been modest to date [7–11].”
- Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010, result): “However, multiple other studies did observe an emergence of all invasive pneumococcal disease caused by serotypes not in the heptavalent vaccine (10, 62, 146, 160, 170, 224), emphasizing the need for continued surveillance and the development of vaccines with efficacy against these other serotypes (”